Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune Sea 500
Great Place To Work
Tech
Tech
Ai
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-suite
Ceo Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
Pharmaceutical Industry
Pharmaceutical Industry
Page 13 of 100
Finance
Denmark’s economy shrinks 1.8% on reduced pharma production, showing extent of Novo Nordisk dependency
By
Sanne Wass
and
Bloomberg
May 21, 2024
Retail
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
By
Ashleigh Furlong
and
Bloomberg
May 21, 2024
Health
Hims will follow its Viagra playbook and offer weight-loss drugs that are 85% cheaper than Wegovy—with Mounjaro and Zepbound in its sights next
By
Madison Muller
,
Jessica Nix
and
Bloomberg
May 20, 2024
Health
Weaning off Ozempic slowly instead of quitting abruptly can help prevent patients from regaining weight, study says
By
Ashleigh Furlong
and
Bloomberg
May 12, 2024
Tech
Google DeepMind and Isomorphic Labs reveal AI able to predict large swathes of molecular biology
By
Jeremy Kahn
May 8, 2024
Newsletters
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
By
Sheryl Estrada
May 3, 2024
Health
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
By
Sunny Nagpaul
May 2, 2024
Finance
Johnson & Johnson’s latest gambit to solve its massive talcum powder asbestos issue: A $6.5 billion settlement, paid out over 25 years
By
Will Daniel
May 1, 2024
Health
Superbugs could lower your life expectancy by nearly 2 years, report says. What to know about antimicrobial resistance
By
Lindsey Leake
April 26, 2024
Newsletters
AI for drug discovery draws a $1 billion launch—and a lot of hope
By
Sage Lazzaro
April 25, 2024
Leadership
Pharmaceutical giant Bayer’s manager cull will likely affect thousands of bosses—and the aspirin inventor thinks it will help its ‘brilliant’ Gen Z grads to thrive
By
Orianna Rosa Royle
April 24, 2024
Newsletters
How Moderna’s CIO helps steer the drugmaker’s post-COVID evolution
By
John Kell
April 17, 2024
Leadership
Pharmaceutical giant Bayer is getting rid of bosses and asking nearly 100,000 workers to ‘self-organize’ to save $2.15 billion
By
Orianna Rosa Royle
April 11, 2024
Success
Major investors say AstraZeneca boss is ‘massively underpaid’ on $21.5 million salary, despite earning more than double Novo Nordisk’s CEO
By
Ryan Hogg
April 10, 2024
Health
Many cancer drugs remain unproven 5 years after accelerated approval, a study finds
By
Carla K. Johnson
and
The Associated Press
April 8, 2024
Most Popular
Innovation
Rivian's CFO hints the end of EV tax credits means manufacturers are being forced to finally make more affordable...
By
Jordyn Grzelewski
and
Tech Brew
Success
CEO of $62 billion software giant Workday's warning: 'There's nothing more dangerous than yesterday's success'
By
Emma Burleigh
Big Tech
Thanks to a donation from a Silicon Valley billionaire, the nation's largest police fleet of Tesla Cybertrucks is about...
By
Jessica Hill
and
The Associated Press